We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Addresses Pivotal Trial Design in Draft Devices Guidance
U.S. FDA Addresses Pivotal Trial Design in Draft Devices Guidance
September 2, 2011
Recommendations on subject and endpoint selection and minimizing bias dominate a new U.S. Food and Drug Administration (FDA) guidance on device clinical study designs.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor